Previous studies have demonstrated the proliferation stimulating effects of HPV and FA administration on oral cancers may suggest that concomitant removal or reduction of p53 and Rb tumor suppression pathways and increased folate bioavailability could greatly amplify cellular growth [7,8,22,24,27]. The gene discussed is TP53; the disease is lip and oral cavity carcinoma.